Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma

Clinical trial NCT00354523 · TERMINATED

Trial details

NCT number: NCT00354523
Sponsor: M.D. Anderson Cancer Center
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor Thyroid Cancer

Start date: 2004-12-01
Primary completion: 2006-11-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.